Aqylon Nexus (AQYLON)

FairStock Score: 30/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding at 59.12% aligns insiders with minority shareholders.
• Piotroski F-score of 7/9 suggests reasonable recent financial health on the numbers available.
• Latest quarter is profitable: ₹5 Cr sales and ₹1 Cr net profit, a positive sign after the sharp decline.
• Sales growth of 109.75% and profit growth of 1,000% show momentum, though from a tiny base.

Concerns

• Market cap of ₹3,048 Cr against annualised profit of roughly ₹4 Cr implies an extreme valuation; P/E 0.00 and P/B 11.90 leave no margin of safety.
• Reported free cash flow is –₹20.53 lakh Cr, a severe negative that contradicts the reported profit.
• The 52-week range of ₹22.25–₹1,714.90 and current price of ₹49.61 reflect extreme volatility and possible value-trap behaviour.
• Zero dividend yield and tiny absolute sales/profit figures make the high growth rates unreliable.

AI Analysis

At ₹49.61, Aqylon Nexus is not an investment; it is a speculative wager. The market capitalisation is ₹3,048 crore, but the latest quarter shows sales of only ₹5 crore and net profit of ₹1 crore. Even if I annualise that profit, I am paying roughly 750 times earnings—and the P/E of 0.00 tells me trailing earnings are nonexistent. Book value is ₹4.17 per share, so the price-to-book of 11.90 forces me to pay a huge premium for a thin equity base. I see high sales growth of 109.75% and profit growth of 1,000%, but these percentages are meaningless when the base is ₹5 crore and ₹1 crore. Doubling from nothing is still close to nothing. ROE and ROCE of 124.61% and 143.24% look astonishing, but with book value that small, small absolute profits create large ratios. I find no sign of a durable moat—no pricing power, no scale, no stable free cash flow. In fact, free cash flow is reported at –₹20.53 lakh crore, which is a disqualifying negative for any company, let alone a ₹3,048 crore one. The 52-week range of ₹22.25 to ₹1,714.90 shows the market already knows this is a low-quality, volatile story. Promoter holding of 59.12% is a mild positive, and Piotroski F-score of 7/9 suggests some recent financial health, but the FairStock Score of 25/100 sums up the risk. There is no dividend, so shareholders see no return while waiting. I would rather watch from the sidelines. In Graham's words, the stock market is a voting machine in the short run and a weighing machine in the long run; this business does not yet weigh enough to justify the price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer